Early Diagnostic Response Model (EDRM)
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT05419895
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Months - 36 Months
- Healthy Volunteers
- Not accepted
Interventions
- Early Diagnostic Response Model (EDRM) — BEHAVIORALUse of telehealth capabilities to implement measures and capture and code information related to an autism diagnosis. This program evaluation will be using pre- and post-data and data collected through the process to evaluate the effectiveness of the EDRM pilot.
Study Details
Babies Can't Wait (BCW) in Georgia will be referring families with children seeking an autism spectrum disorder (autism) diagnosis at the Emory Autism Center's (EAC) Child Screening and Assessment Clinic.The objective of this study is to develop, pilot, and evaluate a diagnostic protocol for children identified at high risk for autism in the BCW early intervention program screening (part of a public health service). This program evaluation will be using pre- and post-data and data collected through the process to evaluate the effectiveness of the EDRM pilot.
Key Dates
- Start date
- Jun 16, 2022
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Families with children enrolled in BCW with suspected diagnosis of autismPost-consent, families with children between 16-33 months will receive a link to complete the EAC Developmental History Survey on REDCap and a link to complete parent/caregiver questionnaires about developmental and/or adaptive information. Then, the family will be assigned to a clinician for the autism assessment and scheduled their assessment and feedback session (one week later).
Primary Outcome Measure
Number of participants referred to the Early Diagnostic Response Model (EDRM) [ Time Frame: Until the end of the study (approximately one year) ]
Central Contacts
- Allison Schwartz, PhD404.727.8350
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory Autism Center | Atlanta | Georgia | 30322 |
Find similar trials in Atlanta, GA
Related Studies
- Screening for Autism in 9-Month-Olds by Measuring Social Visual EngagementRecruiting · Emory University · Atlanta, Georgia
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Phoenix, Arizona
- Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum DisorderPHASE1 · Recruiting · Intra-Cellular Therapies, Inc. · Miami, Florida
- Evaluating Georgia Part C Implementation OutcomesRecruiting · Emory University · Atlanta, Georgia